Figure 1.
![Figure 1. Effects of hLL1 and rituximab on proliferation of cell lines. Antiproliferative effects of the anti–B-cell mAbs were assessed by measuring the uptake of [3H]-thymidine. Cells were cultured with the mAbs with or without a second antibody for cross-linking to mimic the role of effector cells or cross-linking molecules present in vivo. Error bars represent standard deviations (SD). (A) NHL cell lines incubated with hLL1. (B) NHL cell lines incubated with rituximab. (C) MM cell lines incubated with hLL1. (D) MM cell lines incubated with rituximab. *Not determined.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/104/12/10.1182_blood-2004-03-0890/5/zh80230469970001.jpeg?Expires=1758107667&Signature=lIvAtftcmklJLhq8M9Ol9Jdl~BUclYYxWHCUNQIZpq3I5r7vXYKHncwD4kfOpQon1PN~tHKTyFiCqQ~GJsX6dlbIUAphlzwqv-3Wkoc7FfRyjTYdIy9Aq3cgwlyV2ZYeyHWGUr~PXtzKIF1sGjk3djEFPABKFzWBPkMEuD~nFk1EscXHD4QQPTpD3yvnSGHyH4ff3C6wUDfjHsxHAIIAEs5gERLgcfhS7vcjhwjZrY8M1X8EgD0AHozDAs4HmzQ7HNDMhhIMDJs46D-ND62QDrP5jylnevuXkHVtUUlT5NNcYzzT7~4WcVBNDPk5DErCKW5uf2-s5KKzGFoa41VHOQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effects of hLL1 and rituximab on proliferation of cell lines. Antiproliferative effects of the anti–B-cell mAbs were assessed by measuring the uptake of [3H]-thymidine. Cells were cultured with the mAbs with or without a second antibody for cross-linking to mimic the role of effector cells or cross-linking molecules present in vivo. Error bars represent standard deviations (SD). (A) NHL cell lines incubated with hLL1. (B) NHL cell lines incubated with rituximab. (C) MM cell lines incubated with hLL1. (D) MM cell lines incubated with rituximab. *Not determined.
